Freiburg TIPS Registry
Recruiting · NCT05782556 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital Freiburg
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial. Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 months after TIPS implantation following a regular follow-up schedule with clinical visits at the University Medical Center Freiburg. During follow-up visits, serum/plasma samples and peripheral blood mononuclear cells (PBMC) are collected and stored in a associated biobank.
Who can take part
Inclusion criteria
- Patients allocated to TIPS implantation due to clinically significant cirrhotic and non-cirrhotic portal hypertension
Exclusion criteria
- Withdrawal of written informed consent
Where it is running
1 location listed.
- University Medical Center Freiburg, Department of Medicine II - Freiburg im Breisgau, Germany